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Abstract
There is a long history of eye movement research in patients with psychiatric diseases for which dysfunctions of
neurotransmission are considered to be the major pathologic mechanism. However, neuromodulation of oculo-
motor control is still hardly understood. We aimed to investigate in particular the impact of dopamine on smooth
pursuit eye movements. Systematic variability in dopaminergic transmission due to genetic polymorphisms in
healthy subjects offers a noninvasive opportunity to determine functional associations. We measured smooth
pursuit in 110 healthy subjects genotyped for two well-documented polymorphisms, the COMT Val158Met
polymorphism and the SLC6A3 3=-UTR-VNTR polymorphism. Pursuit paradigms were chosen to particularly
assess the ability of the pursuit system to initiate tracking when target motion onset is blanked, reflecting the
impact of extraretinal signals. In contrast, when following a fully visible target sensory, retinal signals are available.
Our results highlight the crucial functional role of dopamine for anticipatory, but not for sensory-driven, pursuit
processes. We found the COMT Val158Met polymorphism specifically associated with anticipatory pursuit
parameters, emphasizing the dominant impact of prefrontal dopamine activity on complex oculomotor control. In
contrast, modulation of striatal dopamine activity by the SLC6A3 3=-UTR-VNTR polymorphism had no significant
functional effect. Though often neglected so far, individual differences in healthy subjects provide a promising
approach to uncovering functional mechanisms and can be used as a bridge to understanding deficits in patients.
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Significance Statement
Although the neuronal bases of oculomotor control are well documented, the modulating role of neurotrans-
mitters has remained elusive. Oculomotor deficits have been reported in diseases characterized by
disturbed neurotransmission; however, clinical findings lack specificity and are ambiguous because of
confounding issues. We used genetic polymorphisms in healthy subjects as an elegant way to investigate
the effect of individual differences in dopaminergic circuitry on smooth pursuit eye movements. We found
a specific impact of prefrontal dopamine on high-level, but not on low-level, processes involved in pursuit.
Our results provide an immediate link between dopamine and oculomotor control in humans. They highlight
the value of individual differences for uncovering functional processes and provide insight into the
mechanisms underlying oculomotor phenotypes of diseases.
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Introduction
The neural circuits involved in oculomotor control are
well described (Krauzlis, 2005), but understanding of the
role of neurotransmitters in the fine regulation of sensori-
motor processes has remained elusive so far. Dopamine
in particular has been discussed as a functionally signifi-
cant neurotransmitter because of pronounced oculomo-
tor deficits in patients with schizophrenia (Calkins et al.,
2008), a disease for which a dysfunction of dopaminergic
transmission is considered to be the major pathologic
mechanism (Abi-Dargham and Moore, 2003). However,
clinical findings are mixed, and links to dopamine are
tenuous.
Direct support for the link between dopamine and oc-
ulomotor control has recently come from neurophysiology
studies in monkeys (Noudoost and Moore, 2011). By
pharmacological manipulation of prefrontal dopaminergic
transmission, it was possible to modulate visual cortical
signals in area V4 that contribute to saccadic target se-
lection. The crucial question that has not been sufficiently
answered yet is whether dopaminergic modulation of eye
movements can also be seen in healthy human observers.
Pharmacological challenge studies indicate that applica-
tion of dopamine antagonists can disrupt smooth pursuit
eye movements (Malaspina et al., 1994; Reilly et al.,
2008), but specificity of deficits and reliability of results
remained unclear. An alternative noninvasive way to in-
vestigate behavioral effects of dopamine in humans is
provided by genetic polymorphisms functionally associ-
ated with neurotransmission.
The COMT (catechol-O-methyltransferase) Val158Met
polymorphism [rs4680] and the SLC6A3 3=-UTR-VNTR
polymorphism [rs28363170] represent two well-studied
dopaminergic polymorphisms (Vandenbergh et al., 1992;
Lachman et al., 1996). Fig. 1 illustrates their proposed
functional mechanisms.
Activity of the dopamine-degrading enzyme COMT is
modulated by a single-nucleotide polymorphism. The en-
coding gene is subject to a mutation that results in a
substitution of methionine (Met) for valine (Val) at codon
158. The Met allele is associated with reduced enzyme
activity, leading to less efficient dopamine catabolism. In
Val/Val homozygotes, a three- to four-fold higher activity
than in Met/Met homozygotes is observed; Val/Met
heterozygotes show intermediate activity levels (Lachman
et al., 1996). Less active COMT contributes to higher
dopamine levels. This mechanism is dominant in prefron-
tal cortex because of a local lack of alternative breakdown
mechanisms (Tunbridge et al., 2006). In striatal regions,
dopamine regulation relies on the dopamine active trans-
porter (DAT) that terminates dopamine activity by re-
uptake from the synaptic cleft. Its availability is modulated
by a variable number of tandem repeats polymorphism of
the 3=-untranslated region (UTR) of the encoding gene
(Vandenbergh et al., 1992; Costa et al., 2011; Faraone
et al., 2014). Repeats range between 3 and 13, with 9- and
10-repeat alleles having the highest frequency in the pop-
ulation (Kang et al., 1999). Although the functional mech-
anism holds some tentativeness, converging evidence
from meta-analyses supports higher DAT availability in
carriers of the 9-repeat allele. Lower DAT availability in
noncarriers putatively slows down reuptake and thereby
increases dopamine activity (Costa et al., 2011; Faraone
et al., 2014).
Although a variety of behavioral correlates of both poly-
morphisms have been studied, insights into their role in
oculomotor control are sparse. Some findings point to
functional associations with antisaccade performance (Et-
tinger et al., 2008; Haraldsson et al., 2010; Kasparbauer
et al., 2015), but differences foremost showed up in BOLD
responses. Smooth pursuit seems ideal for studying dif-
ferent mechanisms involved in oculomotor control, be-
cause it relies on a sophisticated interplay between
motion perception, sensorimotor transformation, and an-
ticipatory abilities (Lisberger, 2010; Kowler et al., 2014).
However, the link between both polymorphisms and indi-
vidual variations in pursuit has not been investigated ap-
propriately yet. Studies focused primarily on pursuit
deficits in schizophrenic patients (Rybakowski et al.,
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Figure 1. Putative functional mechanisms of dopaminergic poly-
morphisms. A, COMT Val158Met polymorphism: genotype mod-
ulates activity of the COMT enzyme that represents the major
dopamine breakdown mechanism in prefrontal cortex; lower
enzyme activity results in higher prefrontal dopamine activity. B,
SLC6A3 3=-UTR-VNTR polymorphism: genotype modulates
availability of the DAT that terminates striatal dopamine activity
by fast reuptake from the synaptic cleft; lower availability of the
transporter results in higher striatal dopamine activity.
New Research 2 of 13
November/December 2016, 3(6) e0190-16.2016 eNeuro.org
2002; Thaker et al., 2004; Haraldsson et al., 2009; Wonodi
et al., 2009). Although healthy subjects were included as
control groups, procedures might have been not well
suited to detect individual differences in the normal range
and particularly in different pursuit parameters. Conclu-
sions have been complicated by inconsistent results and
insufficient differentiation between specific pursuit mech-
anisms.
We aimed to shed light on the role of dopamine in
oculomotor control by studying the link between dopami-
nergic polymorphisms and smooth pursuit, specifically in
healthy subjects. We acknowledge the complexity of reg-
ulatory processes during pursuit by considering selective
oculomotor measures that emphasize either the role of
low-level or high-level signals involved. This distinction
alludes to the specific functional contributions of retinal
sensory signals and extraretinal signals, including, e.g.,
attention, learning, prediction, or anticipation (Yasui and
Young, 1975; Robinson et al., 1986; compare also Kowler
et al., 2014). Low-level signals drive bottom-up control,
whereas high-level signals account for top-down control.
We investigated their associations with two polymor-




A total of 110 subjects (18 males) participated in our
study. Age ranged from 18 to 45 years, with a mean age
of 23.7 years (SD 5.1). Subjects were undergraduate stu-
dents enrolled in the psychology program at the Justus
Liebig University Giessen and fulfilled requirements of the
study program with their participation. All students were
naive with respect to the purpose of the study. Any history
of neurological or psychiatric disorders as well as medi-
cations or drug use presumed to interfere with oculomotor
functioning were screened out by a comprehensive inter-
view protocol. Methods and procedures agreed with the
Declaration of Helsinki (World Medical Association, 2013).
Informed consent was obtained by all participants, and
protection of data privacy was provided.
Genotyping
Genetic analyses were conducted within the Gene
Brain Behaviour Project (GGBBP) run by the Department
of Psychology at the Justus Liebig University Giessen.
The project maintains a large subject database charac-
terized by selected polymorphisms functional for neu-
rotransmission and available for behavioral research. All
genetic analyses are performed and documented by an
experienced technician in the local GGBBP laboratory.
DNA was extracted from buccal cells and purified with a
commercial extraction kit (MagNAPure LC DNA, Roche
Diagnostics).
For the COMT Val158Met polymorphism [rs4680], geno-
typing was accomplished by PCR and fluorescence
melting-curve detection analysis. We used the Light Cy-
cler System (Roche Diagnostics, RRID: SCR_001326).
Amplification and detection were performed using Light
Cycler FastStart DNA Master Hybridization Probes
(Roche Diagnostics, RRID: SCR_001326) with the follow-
ing contents: reaction buffer, dNTPs mix, and Taq DNA
polymerase (0.7) plus 1.6 mM magnesium chloride, 0.6
M of each of the primers, 0.2 M of each of the hybrid-
ization probes, and 50 ng of genomic template DNA. All
reactions were carried out in a total volume of 21.4 l.
Primers and hybridization probes (TIB Molbiol) were as fol-
lows: forward primer, 5=-GGGCCTACTGTGGCTACTCA-3=;
reverse primer, 5=-GGCCCTTTTTCCAGGTCTG-3=; anchor
hybridization probe, 5=-LCRed640-TGTGCATGCCTGAC-
CCGTTGTCA-phosphate-3=; sensor hybridization probe, 5=-
ATTTCGCTGGCATGAAGGACAAG-fluorescein-3=. The
PCR run comprised 53 cycles of denaturation (95°C, 0 s,
ramp rate 20°C/s), annealing (57°C, 10 s, ramp rate 20°C/s),
and extension (72°C, 10 s, ramp rate 20°C/s), which followed
an incubation period of 10 min at 95°C to activate the
FastStart Taq DNA polymerase of the reaction mix. The
fluorescence signal was plotted against temperature to yield
the respective melting points (Tm) of the two alleles. Tm for
the Val allele was 59°C, and for the Met allele, 64.5°C.
For the SCL6A3 3=-UTR-VNTR polymorphism
[rs28363170], genotyping was accomplished by PCR and
gel electrophoresis. DNA amplification reactions were
performed as described below, using a Mastercycler EP
(Eppendorf, RRID: SCR_000786). PCR amplifications
were performed in 25-l reaction volumes containing50
ng of genomic template DNA, 0.08 U/l of Qiagen TopTaq
DNA polymerase, 1 PCR buffer, and 0.4 mM dNTP mix
(Qiagen), 1 BSA, 2 DMSO, and 0.6 M each of forward
(5=-TGTGGTGTAGGGAACGGCCTGAG-3=) and reverse
(5=-CTTCCTGGAGGTCACGGC TCAAGG-3=) primers (TIB
Molbiol). Thermal cycling consisted of a 7-min initial de-
naturation phase at 95°C followed by 35 cycles of 95°C
(45 s), 63°C (45 s), and 72.8°C (60 s), with a final extension
step of 5 min at 72.8°C. Finally, 12 l of the PCR product
was separated by means of gel electrophoresis on a 3%
agarose gel in Tris/borate/EDTA buffer (160 V, 60 min) and
visualized by ethidium bromide.
Distributions of genotypes for both polymorphisms are
given in Table 1. For the SCL6A3 3=-UTR-VNTR polymor-
phism, we found four subjects who carried an 11-repeat
allele. Because these genotypes are extremely rare, such
Table 1. Distributions of genotypes and Hardy–Weinberg equilibrium test statistics
Polymorphism Frequency (n) of genotype 2 p
COMT Val158Met [rs4680] Val/Val: 24 Val/Met: 54 Met/Met: 32 0.019 0.89
SCL6A3 3=-UTR-VNTR [rs28363170] 9/9: 8 9/10: 42 10/10: 56 0.001 0.97
Val/Val, homozygote valine/valine; Val/Met, heterozygote valine/methionine; Met/Met, homozygote methionine/methionine; 9/9, homozygote 9-repeat/9-repeat;
heterozygote 9-repeat/10-repeat; 10/10, homozygote 10-repeat/10-repeat.
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subjects are commonly ignored in association studies. We
congruently excluded the 11-repeat allele carriers from
further analyses so that our sample was reduced to 106
subjects. Hardy–Weinberg equilibrium tests yielded sig-
nificant deviations for neither polymorphism.
Pursuit tasks
Smooth pursuit eye movements were recorded in an
anticipatory and a visually guided task. In visually guided
pursuit, initiation is driven by low-level, retinal signals.
During the following steady-state phase, high-level ex-
traretinal signals contribute to pursuit maintenance, but
retinal signals are continuously integrated (Yasui and
Young, 1975; Robinson et al., 1986). In contrast, antici-
patory pursuit is suited to measure specifically high-level
mechanisms of oculomotor control because retinal mo-
tion signals are eliminated. Fig. 2 illustrates both para-
digms by individual eye position traces of an exemplary
subject. The pursuit target was a black dot with a diam-
eter of 0.5° moving on a uniform gray background. The
luminances for gray and black pixels were 41.4 and 0.18
cd/m2, respectively, resulting in a Michelson contrast of
99% for the target.
Our anticipatory task corresponded to the established
occluded onset pursuit paradigm (Collins and Barnes,
2006; Freyberg and Ilg, 2008). The target moved at a
constant velocity of 17.6°/s horizontally over a distance of
32°. Trials started with an initial fixation period of 500 ms.
A fixation dot equivalent to the pursuit target was pro-
vided at 16° either left or right from the center of the
screen, both randomized and balanced across trials. Fix-
ation dot position indicated direction of subsequent target
motion. It started to the right or to the left, respectively,
immediately after the fixation period. In a learning phase
consisting of 10 trials, subjects were trained to pursue the
moving target and were given the opportunity to build up
a stable movement expectation. Subsequently, in 50% of
a total of 40 trials, the target was blanked for 500 ms after
motion onset. The offset of the fixation target here pro-
vided the signal for pursuit initiation. Trials with visible
target and blanked target were randomly interleaved to
stabilize anticipation. To measure visually guided pursuit
in a paradigm as similar as possible to the anticipatory
paradigm, we used ramp target movements in our visually
guided task. Fixation at trial start was set to the center of
the screen and varied in duration uniformly between 600
and 1100 ms. This jitter was introduced to avoid antici-
patory responses. Next the target started to move hori-
zontally from the center of the screen either to the right or
to the left. Target direction was randomized and bal-
anced. Target velocity was held constant at 17.6°/s. Sub-
jects self-initiated trials in both pursuit tasks by pressing
the space bar.
Eye tracking equipment
Stimuli were generated using Matlab (RRID:
SCR_001622) with the Psychophysics Toolbox extension
(Brainard, 1997, RRID: SCR_002881). They were dis-
played on a 21-inch SONY GDM-F520 CRT monitor
driven by an Nvidia Quadro NVS 290 graphics board with
a refresh rate of 100 Hz noninterlaced. The spatial reso-
lution was set to 1280  1024 pixels. Subjects were
seated in a darkened room at a distance of 47 cm in front
of the monitor. Eye movements were registered by a SR
Figure 2. Pursuit paradigms. A, Anticipatory pursuit task: we
established a stable expectation of target motion, i.e., fixed
direction and velocity; each trial began with a period in which the
target trajectory was blanked; the target became visible only
after 500 ms. B, Visually guided pursuit task: in a ramp paradigm,
the target was visible throughout each trial; motion direction
randomly varied from trial to trial; thus motion trajectories were
not predictable. Targets moved at a constant velocity of 17.6°/s,
and positions are illustrated by black solid and gray dashed lines,
respectively; individual eye position traces of an exemplary sub-
ject are shown in red.
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Research Eyelink 1000 Tower Mount system (SR Re-
search, RRID: SCR_009602) at a sampling rate of 2000
Hz. Viewing was binocular, and the subject’s head was
stabilized by a chin- and headrest. A 9-point calibration
was applied, and accuracy was accepted if the procedure
yielded values of average error not larger than 0.4° and
worst error not larger than 0.7°.
Data analysis
Genotyping and eye tracking experiments were carried
out in parallel and were performed independently. Genetic
and behavioral data were combined only after completion
of data collection; thus measurement of pursuit was blind
to subject genotype.
The COMT Val158Met polymorphism was entered in the
analyses with three levels according to the genotypes,
namely Val/Val, Val/Met, and Met/Met. For the SLC6A3
3=-UTR-VNTR polymorphism, two subgroups were con-
sidered. Given the low prevalence of 9-repeat homozy-
gous individuals, subjects were grouped into 9-repeat
allele carriers (DAT9) and noncarriers (DAT9–). Table 2
shows frequencies of the defined levels for both polymor-
phisms. As mentioned above, four subjects who carried
an 11-repeat allele of the SLC6A3 3=-UTR-VNTR polymor-
phism were excluded from analyses due to the rareness
of their genotype.
Eye position traces were analyzed offline. We obtained
eye velocity traces by differentiation of position signals
over time. Position and velocity traces were smoothed by
a Butterworth filter with cutoff frequencies of 30 and 20
Hz, respectively. Saccades were detected using the stan-
dard algorithm provided by Eyelink software, which is
based on a saccade velocity threshold of 30°/s and a
saccade acceleration threshold of 9500°/s. We removed
saccades as well as a period of 15 ms before and after
saccade onset and offset from the traces. Velocity signals
during saccades were replaced by linear interpolation
between the velocity before and after each saccade.
As parameters of interest in the visually guided pursuit
task, we analyzed pursuit latency, steady-state velocity
gain, and pursuit ratio within a time window of 400–700
ms after target motion onset. Pursuit onset was deter-
mined for each individual velocity trace by an established
procedure using the best fitting regression line in a spec-
ified time interval (Schütz et al., 2007). Pursuit ratio has
been introduced by Liston and Stone (2014) as a critical
steady-state tracking metric and gives the proportion of
eye displacement during pursuit relative to the total eye
displacement during a given interval. Anticipatory pursuit
response was described by maximum eye velocity during
the blank period, by average eye velocity in the last 100 ms
of the blank period, and by eye position at the end of the
blank period. In addition, we analyzed pursuit latency after
visible target onset, amplitude of the first catch-up saccade,
and distance between its endpoint and target position. The
latter metric was termed amplitude lag and provides a mea-
sure how far the eye lags behind the target after the first
catch-up saccade. Finally, we also considered steady-state
velocity gain and pursuit ratio when the target had become
visible after the blank period and thereby obtained additional
measures for visually guided pursuit.
Results
We analyzed the association between smooth pursuit
parameters and dopaminergic polymorphisms by multi-
variate ANOVA (MANOVA), with pursuit parameters as
dependent variables and levels of the COMT Val158Met
polymorphism and the SLC6A3 3=-UTR-VNTR polymor-
phism as independent variables. The COMT Val158Met
polymorphism was entered with three levels, Val/Val, Val/
Met, and Met/Met; the SLC6A3 3=-UTR-VNTR polymor-
phism was entered with two levels, DAT9 and DAT9–. If
appropriate, follow-up univariate ANOVAs were run sep-
arately for each dependent variable. In addition, we ex-
plored how well specific parameters allowed classification
of genotype groups by receiver operating characteristic
(ROC) analyses.
Our data showed that only anticipatory pursuit pro-
cesses are subject to pronounced dopaminergic modula-
tion, in particular by the COMT Val158Met polymorphism.
Fig. 3 illustrates eye position and velocity traces in the
anticipatory pursuit task for the different genotypes of the
COMT Val158Met polymorphism and the SLC6A3 3=-UTR-
VNTR polymorphism, respectively.
To investigate the effect of the polymorphisms on an-
ticipatory pursuit, we chose the pursuit metrics that are
most indicative for the anticipatory response and entered
them as dependent variable into a MANOVA. In particular,
we considered anticipatory velocity and position during
the blank period, but also pursuit latency after visible
target onset, amplitude of the first catch-up saccade, and
distance between its endpoint and target position. Al-
though the last three metrics apply to an interval in which
the target was visible and thus pursuit was also driven by
retinal signals, they crucially depend on the purely antic-
ipatory extraretinal response during the period when the
target was blanked. Results showed a significant main
effect of the COMT genotype (V  0.37, F(12,192)  3.68,
p  0.001, 2  0.19) that explains overall 19% of vari-
ance. We found neither a main effect of the DAT factor (V
 0.04, F(6,95)  0.67, p  0.677, 2  0.04) nor an












Val/Val, homozygote valine/valine; Val/Met, heterozygote valine/methionine;
Met/Met, homozygote methionine/methionine; DAT9, carriers of the 9-re-
peat allele, DAT9–, noncarriers of the 9-repeat allele.
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interaction effect of both polymorphisms (V  0.08,
F(12,192)  0.63, p  0.817, 2  0.04).
Follow-up univariate ANOVAs on separate parameters
revealed that individuals with COMT genotypes putatively
associated with higher prefrontal dopamine levels, i.e.,
carriers of the Met allele, showed a boost in anticipatory
pursuit response in absence of a visible target (Fig. 4A–C).
During the anticipatory phase, their eyes initially reached
a higher peak velocity, close to 60% of the anticipated
target velocity, compared with 45% for Val allele homozy-
gotes (F(2,100) 4.04, p 0.021, 2 0.08). These peak
velocity values are considerably higher than those given
by the average velocity traces shown in Fig. 3A because
the point in time when eye velocity peaked during the
blank period substantially varied between individual sub-
jects. However, distribution pattern did not depend on
genotype. The advantage was maintained up to visible
target onset, when we still found a significant genotype
effect on eye velocity (F(2,100)  4.93, p  0.009, 2 
0.09) as well as on eye position (F(2,100)  14.07, p 
0.001, 2 0.22). Met allele homozygotes showed an eye
velocity almost twice as high as Val allele homozygotes,
i.e., 3.1°/s versus 1.7°/s. In addition, their eye position
was closer to the target, at 4.8° versus 2.0°.
After target appearance, the anticipatory advantage of
Met allele carriers was carried forward (Fig. 4D–F). Pursuit
initiation took 30 ms less (F(2,100)  4.72, p  0.011,
2  0.09). Their first catch-up saccade was of smaller
amplitude, 6° versus 8° in Val allele homozygotes
(F(2,100)  6.17, p  0.003, 2  0.11). At the same time,
it landed closer to the target, resulting in a lag of 1° versus
2° in Val allele homozygotes (F(2,100)  6.59, p  0.002,
2  0.12). Notably, the advantage was completely can-
celled in the steady-state pursuit phase. Neither velocity
gain nor pursuit ratio differed between the three COMT
genotype groups (Fig. 4G, H).
As revealed by the initial MANOVA, the SCL6A3 3=-
UTR-VNTR polymorphism was not associated with antic-
ipatory pursuit processes. Figs. 3 and 4 illustrate that the
anticipatory pursuit response of carriers and noncarriers
of the 9-repeat allele completely overlapped. Genotype
groups did not differ in any of the anticipatory pursuit
metrics.
Given these results, we furthermore performed ROC
analyses to investigate how well pursuit parameters dif-
ferentiate between genotypes of the COMT Val158Met
polymorphism. Results are summarized in Table 3. The
area under the curve (AUC) illustrates classification per-
formance for each metric; a value of 1 corresponds to
perfect classification, whereas a value of 0.5 corresponds
to random classification. Scores show that anticipatory
pursuit parameters consistently allow successful discrim-
ination between Val/Val and Met/Met genotypes as well
as between Val/Val and Val/Met genotypes. Val/Met and
Met/Met genotype groups, in contrast, showed very sim-
ilar pursuit patterns, and ROC scores indicate that most
Figure 3. Association between dopaminergic polymorphisms and anticipatory smooth pursuit eye movements. A, Horizontal eye
position and velocity traces for different genotypes of the COMT Val158Met polymorphism. B, Horizontal eye position and velocity
traces for different genotypes of the SCL6A3 3=-UTR-VNTR polymorphism. Note that saccades are removed from our data so that
position and velocity traces are not directly comparable. Shaded areas, SEM; dotted lines, target position.
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Figure 4. Association between dopaminergic polymorphisms and anticipatory smooth pursuit eye movements. Pursuit metrics are given for the
COMT Val158Met polymorphism and the SCL6A3 3=-UTR-VNTR polymorphism side by side. A, Peak horizontal eye velocity during the 500-ms
blank period when the target was not visible; note that values here differ from the average velocity traces because of temporal variability in
individual observers. B, Average horizontal eye velocity in the last 100 ms of the blank period before the target became visible.C, Horizontal eye
position at the end of the blank period when the target became visible.D, Pursuit latency after visible target onset. E, Amplitude of first catch-up
saccade (CS) after visible target onset.F, Amplitude lagof first catch-upsaccade (CS) after visible target onset.G, Velocity gainduring steady-state
pursuit. H, Pursuit ratio during steady-state pursuit. Error bars: SEM.
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parameters discriminate only insufficiently between the
two genotypes.
Although anticipatory pursuit was clearly modulated by
the COMT Val158Met polymorphism, visually guided pur-
suit was not affected by the investigated dopaminergic
polymorphisms. Results of the MANOVA with the three
parameters of interest in the visually guided pursuit task
as dependent variables yielded no significant main effects
of the COMT factor (V  0.06, F(6,198)  0.96, p  0.457,
2  0.03) or the DAT factor (V  0.01, F(3,98)  0.36,
p  0.786, 2  0.01). Also, the interaction of the two
polymorphisms did not reach significance (V  0.04,
F(6,198)  0.64, p  0.697, 2  0.02). Fig. 5 demon-
strates equivalent visually guided pursuit processes
across the defined levels of the COMT Val158Met poly-
morphism and the SCL6A3 3=-UTR-VNTR polymorphism.
A direct comparison between classification performance
of anticipatory and visually guided metrics for COMT
genotypes is provided in Table 3. ROC scores corroborate
that only anticipatory pursuit parameters discriminate be-
tween COMT genotypes; visually guided pursuit parame-
ters do not provide sufficient classification information.
Discussion
Directed eye movements represent one of the most
fundamental principles of visual information processing in
Table 3. ROC scores of pursuit metrics predicting COMT genotype by pairs
Val/Met vs. Met/Met Val/Val vs. Val/Met Val/Val vs. Met/Met
AUC 95% CI AUC 95% CI AUC 95% CI
Anticipatory pursuit task
Peak velocity 0.56 0.42–0.69 0.70 0.55–0.81 0.73 0.57–0.84
Anticipatory velocity 0.62 0.48–0.74 0.66 0.52–0.78 0.76 0.60–0.86
Anticipatory position 0.70 0.57–0.81 0.72 0.58–0.83 0.86 0.73–0.93
Pursuit latency 0.53 0.40–0.65 0.71 0.57–0.82 0.75 0.60–0.86
First CS amplitude 0.64 0.51–0.75 0.68 0.57–0.79 0.81 0.66–0.90
First CS amplitude lag 0.63 0.49–0.74 0.65 0.51–0.76 0.79 0.64–0.88
Visually pursuit task
Pursuit latency 0.50 0.36–0.63 0.58 0.43–0.72 0.57 0.40–0.72
Velocity gain 0.54 0.41–0.66 0.58 0.42–0.68 0.64 0.47–0.77
Pursuit ratio 0.54 0.41–0.66 0.60 0.47–0.72 0.66 0.50–0.79
95% CI, 95% confidence intervals for the AUC, estimated using a logit model; CS, catch-up saccade.
Figure 5. Association between dopaminergic polymorphisms and visually guided smooth pursuit eye movements. A, Horizontal eye
position and velocity traces for different genotypes of the COMT Val158Met polymorphism. B, Horizontal eye position and velocity
traces for different genotypes of the SCL6A3 3=-UTR-VNTR polymorphism. Note that saccades are removed from our data, so
position and velocity traces are not directly comparable. Shaded areas, SEM; dotted lines, target position. Pursuit metrics (C–E) are
given for the COMT Val158Met polymorphism and the SCL6A3 3=-UTR-VNTR polymorphism side by side. C, Pursuit latency after
target motion onset. D, Velocity gain during steady-state pursuit. E, Pursuit ratio during steady-state pursuit. Error bars: SEM.
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humans. The ability to analyze visual information in detail
relies on eye movements that bring selected targets to the
fovea and stabilize them there. Although there are com-
prehensive models of the functionally involved neural
pathways (Krauzlis, 2005), the impact of specific neu-
rotransmitters on oculomotor control is still hardly under-
stood. This in particular appears surprising, because there
is a long history of eye movement research in patients
with psychiatric diseases that are etiologically character-
ized by a disturbed balance of neurotransmitter activity
(Klein and Ettinger, 2008). We studied smooth pursuit eye
movements in a large sample of healthy subjects geno-
typed for well-documented polymorphisms that modulate
prefrontal and striatal dopaminergic transmission. We
aimed to explore how individual differences in dopamine
activity modulate oculomotor control. Different paradigms
were used that tapped on low-level and high-level mech-
anisms underlying smooth pursuit.
Our results highlight the critical functional role of dopa-
mine for anticipatory pursuit, but not for sensory-driven
pursuit processes. Whereas our data provide clear evi-
dence that anticipatory pursuit is modulated by dopa-
mine, visually guided pursuit was not affected by
dopaminergic polymorphisms. This shows that dopamine
is particularly functional for top-down processes involved
in pursuit. Visually guided pursuit crucially involves
bottom-up processes, so dopaminergic effects are most
likely swamped by low-level sensory noise for estimating
visual motion (Osborne et al., 2005).
Control of smooth pursuit eye movements is based on
a dynamic interplay between low-level retinal and high-
level extraretinal signals (Barnes, 2008; Lisberger, 2010;
Kowler et al., 2014). Sensory and cognitive contributions
are closely interwoven, but rely on differential neuronal
resources. We considered the initiation of anticipatory
pursuit in particular as a prominent indicator of high-level
processes. It has been shown that if upcoming target
motion is predictable, anticipatory pursuit can be elicited
without visual target information (Hemptinne et al., 2006;
Freyberg and Ilg, 2008). The anticipatory pursuit re-
sponses we observed in our study were comparable to
previous reports, but we found them modulated by indi-
vidual differences in dopaminergic transmission. In con-
trast, visually driven pursuit did not systematically vary
across individuals. Previous studies that strived to inves-
tigate the role of dopamine in different pursuit processes
used continuous waveform motion, providing perfectly
predictable target trajectories, and blanked the target for
a short period during ongoing pursuit (Thaker et al., 2004;
Wonodi et al., 2009). Although this approach has yielded
seminal insights into pursuit deficits in schizophrenia pa-
tients, we suggest that using two separate paradigms for
visually guided and anticipatory pursuit allows a more
detailed differentiation between underlying mechanisms.
In a continuous waveform motion paradigm, pursuit dur-
ing a blank period clearly relies on extraretinal mecha-
nisms, but when the target is visible, the degree to which
visual error signals or predictive signals drive pursuit re-
mains ambiguous. In our paradigms, low-level sensory
contributions and high-level anticipation are fully segre-
gated.
In the present study, we considered two functional poly-
morphisms that modulate the twomajor factors in regulation
of dopamine activity, namely COMT by dopamine catabo-
lism in prefrontal cortex and DAT by dopamine reuptake in
striatal regions. For both polymorphisms, COMT Val158Met
and SCL6A3 3=-UTR-VNTR, elaborate functional models
have been derived (Vandenbergh et al., 1992; Lachman
et al., 1996), but reliability of behavioral associations has
been often discussed controversially.
The COMT Val158Met polymorphism has been convinc-
ingly associated with prefrontal cortex function (Yavich
et al., 2007). Systematic differences between genotype
groups were reported for behavioral performance in a
variety of cognitive tasks demanding executive control
(Tunbridge et al., 2006; Barnett et al., 2008; Goldman
et al., 2009) as well as for task-related BOLD activation in
prefrontal brain regions (Mier et al., 2010). Furthermore,
the COMT polymorphism has been assumed to be asso-
ciated with various psychiatric diseases, in particular
schizophrenia (Lachman et al., 1996). However, initial re-
ports of a significant association between the COMT gene
and schizophrenia were not confirmed by later meta-
analyses (Egan et al., 2001; Munafo et al., 2005; Okochi
et al., 2009). Similarly, a putative link between the COMT
polymorphism and specific personality traits, e.g. schizo-
typy, has to be considered as elusive (Montag et al., 2012;
Mohr and Ettinger, 2014). Most likely, the complexity of
psychiatric etiologies or personality traits does not allow
to determine the specific role of the COMT polymorphism,
which might be minor. Our results show that not only
performance in typical cognitive tasks, but also sensori-
motor control in smooth pursuit is crucially modulated by
the COMT genotype. If task characteristics emphasize
top-down control in pursuit, substantial effects of geno-
type are observed. Notably, genotype explained about
19% of variance in the anticipatory pursuit parameters,
which points to a much stronger association than typically
found for performance in cognitive tasks (compare Egan
et al., 2001 and Barnett et al., 2008). Our results also
agree with previous preliminary findings on the link be-
tween the COMT Val158Met polymorphism and pursuit
eye movements that have been reported for healthy con-
trol subjects in a clinical study in schizophrenia patients.
Thaker et al. (2004) showed an advantage in predictive
pursuit for healthy Met allele homozygotes and found
10% of variance in the gain parameter to be explained by
the COMT genotype. In contrast, Haraldsson et al. (2010)
failed to find a significant association in a similar study.
However, they measured pursuit on continuous waveform
motion without target blanking, so extraretinal processes
might have been insufficiently prominent. Both studies
provided only limited insights into differential links be-
tween the COMT Val158Met polymorphism and specific
pursuit processes, because only a single paradigm was
applied.
Our study provides insights into the effects of interin-
dividual differences in dopaminergic transmission that do
not go beyond the normal activity range, and moreover,
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affect individuals permanently across their lives. There-
fore, comparison of our findings with results derived from
pharmacological challenge studies in healthy subjects or
clinical studies in schizophrenia patients requires some
caution. However, we propose that, altogether, findings
from different approaches can be reconciled.
There have been few studies concerned with effects of
dopaminergic drugs on smooth pursuit eye movements in
healthy subjects (Holzman et al., 1975; Malaspina et al.,
1994; King et al., 1995). All studies exclusively considered
steady-state pursuit on a continuously visible target, so
retinal and extraretinal processes were not differentiated
specifically. They provided inconsistent evidence for in-
creased saccadic intrusions when dopaminergic activity
is reduced. In particular, Malaspina et al. (1994) reported
disrupted pursuit after administration of a potent dopa-
mine antagonist, haloperidol. We suggest that these def-
icits are not inconsistent with our conclusion that
dopamine modulates extraretinal, but not retinal, pursuit
processes. Pursuit on a visible target relies on both low-
level and high-level signals. If high-level contributions are
massively blocked, disruptions, i.e., saccadic intrusions,
can be expected. In contrast, more moderate modula-
tions, as by dopaminergic polymorphisms, might not re-
sult in disrupted pursuit. Consistent with this speculation,
studies that did not find increased saccadic intrusions
after drug administration used much less potent dopa-
mine antagonists than Malaspina et al. (1994) (Holzman
et al., 1975; King et al., 1995).
Our findings are also congruent with clinical evidence
from schizophrenia patients and the suggestion that pur-
suit deficits qualify for an endophenotype of the disease
(Klein and Ettinger, 2008). Pursuit deficits were first doc-
umented more than 100 years ago (Diefendorf and Dodge,
1908), and since then an abundance of studies has accu-
mulated confirming a pronounced dysfunction (Trillenberg
et al., 2004; O’Driscoll and Callahan, 2008). Given mas-
sive dopaminergic dysregulation in schizophrenia (Abi-
Dargham and Moore, 2003), it seems plausible to assume
that dopamine contributes to these deficits; however, this
association has remained ill defined because of the com-
plexity of disease and confounding issues in the clinical
setting. It is thus still controversial which specific pro-
cesses contribute to pursuit deficits, but converging evi-
dence strongly suggests that primarily extraretinal
mechanisms are disturbed, whereas sensory driven pro-
cesses are preserved (Thaker et al., 1996, 1998,1999;
Avila et al., 2002; O’Driscoll and Callahan, 2008). It has
been consistently shown that the typical findings of re-
duced gain and increased saccadic intrusions can be
observed most reliably in paradigms emphasizing ex-
traretinal pursuit processes. Whether the pursuit deficit in
schizophrenia patients is modulated by the COMT poly-
morphism is still to be clarified (Rybakowski et al., 2002;
Thaker et al., 2004; Haraldsson et al., 2009; Demily et al.,
2016). Findings are heterogeneous and suggest that the
COMT polymorphism plays a minor role when dopami-
nergic transmission is profoundly disturbed.
Because of the dominance of female subjects in our
sample, the specific effects of the COMT genotype on
high-level pursuit processes might represent a lower
bound for modulation. Functional associations of the
COMT Val158Met polymorphism are subject to sexual di-
morphism (Tunbridge and Harrison, 2011; compare also
Rybakowski et al., 2002). Most likely based on estrogenic
regulation of COMT, the impact of the polymorphism has
been demonstrated to be more consistent for men than
for women (Chen et al., 2004; Barnett et al., 2007; White
et al., 2014). Although our data do not allow any conclu-
sions on sex-specific effects, we therefore suppose that
more pronounced pursuit modulation could be expected
in a sample with a balanced sex ratio. In summary, the
significant association between the COMT Val158Met
polymorphism and anticipatory pursuit processes in
healthy subjects is not only consistent with the estab-
lished functional model, but also provides a specific link
between dopaminergic activity and high-level pursuit
mechanisms.
The functional model of the SCL6A3 3=-UTR-VNTR
polymorphism is also well established, and a critical effect
on dopaminergic transmission in striatal areas is assumed
(Costa et al., 2011; Faraone et al., 2014). Behavioral evi-
dence, though, appears rather heterogeneous. Indeed,
the polymorphism is associated with the risk for develop-
ing attention deficit hyperactivity disorder (Gizer et al.,
2009), and many studies have investigated its effects on
cognition and brain function in this patient group. How-
ever, meta-analytic studies indicate equivocal results
(Rommelse et al., 2008; Dresler et al., 2014). Similarly, a
recent meta-analysis of the association with cognition in
healthy subjects could not find significant evidence (Et-
tinger et al., 2016). Given the pronounced and robust
deficits in schizophrenia patients, we assumed smooth
pursuit eye movements to be especially sensitive to do-
paminergic modulation. In addition, striatal activity has
been shown to contribute to pursuit control in monkeys
(Basso et al., 2005).
Our results yet provide no support for a functional
association between the SCL6A3 3=-UTR-VNTR polymor-
phism and any pursuit process. This finding qualifies the
only previous report on a possible association by Wonodi
et al. (2009). In the context of a clinical study on schizo-
phrenia patients, they found a significant link between the
polymorphism and predictive pursuit in their healthy con-
trol group. However, comparison of results is hampered
by the specific genetic subgroups considered in the pre-
vious study. Results were based on the contrast between
10-repeat homozygous individuals, equivalent to the
DAT9– subgroup in our study, and a group of individuals
with diverse genotypes, including 20% rare genotypes
that were not present at all in our sample. Thus, sample
characteristics might have contributed to conflicting re-
sults.
We cannot exclude that in our data the absence of
pursuit modulation by the SCL6A3 3=-UTR-VNTR poly-
morphism is based on a rather weak association not
detectable with our given sample size. Moreover, it is also
possible that oculomotor parameters after all are not sen-
sitive enough to indicate rather small functional effects of
some genetic polymorphisms. In several studies, for in-
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stance, genotype effects were not observable in behav-
ioral measures, such as in the antisaccade task or stop-
signal tasks, but clearly in brain function measured by
BOLD activity (Ettinger et al., 2008; Congdon et al., 2009;
Kasparbauer et al., 2015). Keeping these possibilities in
mind, we conclude that our data do not provide any
evidence of an association between the SCL6A3 3=-UTR-
VNTR polymorphism and oculomotor control.
Notwithstanding the potential role of striatal dopamine
activity in oculomotor control (compare Hikosaka et al.,
2000 and Basso et al., 2005), our results positively pin-
point the dominant impact of prefrontal dopamine. Antic-
ipatory pursuit in healthy observers is modulated by
COMT activity in prefrontal cortex, but not by DAT avail-
ability in striatal areas. This functional localization agrees
with the neuronal bases of anticipatory pursuit deter-
mined by single-unit recordings in monkeys (Hemptinne
et al., 2008). Cortical dopamine activity, however, is em-
bedded in a frontostriatal circuit involving downstream
projections, and an inverse relationship between prefron-
tal and striatal dopamine activity has been suggested
(Tunbridge et al., 2012). Although detailed dynamics of
dopaminergic regulation elude direct investigation in non-
invasive studies in humans, we tentatively assume that
higher prefrontal dopamine activity triggers attenuated
baseline striatal dopamine levels and thereby enhances
efficiency of phasic striatal dopamine responses encod-
ing anticipated rewards (Bayer and Glimcher, 2005; Gan
et al., 2010). Two studies in rodents have only recently
specified the functional properties of striatal dopamine
(Hamid et al., 2016; Syed et al., 2016), emphasizing com-
bined conveyance of action initiation, motivation, and
learning. A boosted anticipatory pursuit response con-
forms perfectly to an assumed strengthening of these
signaling characteristics. Taking the functional role of stri-
atal transmission for granted, indirect downstream effects
of prefrontal dopamine activity seem to be more powerful
than individual differences because of the SCL6A3 3=-
UTR-VNTR polymorphism that directly modulates striatal
dopamine activity via DAT availability. It is understood
that such a weighting has to be qualified by investigation
of possible functional interactions of both polymorphisms.
However, neither the present study nor previous studies
have provided support for significant interactions (Caldú
et al., 2007; Kasparbauer et al., 2015). To summarize,
specific and localized functional effects of dopamine call
attention to the fact that it is certainly not feasible to define
a global role of dopamine for oculomotor control. Func-
tionality is rather bound to specific dopaminergic subsys-
tems and their embedding in the complex network of
dopaminergic pathways in the brain.
Our approach and our results emphasize the value of
systematic variability and individual differences for uncov-
ering functional processes that would otherwise elude
investigation (Vogel and Awh, 2008; Wilmer, 2008). Ocu-
lomotor control has been studied in extraordinary detail;
nevertheless, there is still a striking discrepancy between
the well-documented oculomotor deficits in diseases pri-
marily characterized by disturbed neurotransmission and
the scarce understanding of which mechanisms drive
these deficits. For example, oculomotor deficits qualify as
one of the most robust endophenotypes (vulnerability
markers) of schizophrenia, but tentative genetic links are
still to be discovered (Gottesman and Gould, 2003). Our
data are congruent with a suggested oculomotor pheno-
type of the disease and furthermore provide insights into
possible underlying mechanisms. Exploiting the effects of
dopaminergic polymorphisms in healthy subjects allowed
us to isolate circumscribed modulation of different pursuit
processes and highlighted the particular impact of pre-
frontal dopamine on anticipatory mechanisms involved in
pursuit. Previous studies identified dopamine receptors in
frontal cortex as central for top-down control of early
visual areas in monkeys (Noudoost and Moore, 2011). We
provide a bridge between these findings and oculomotor
deficits in patients with disturbed dopaminergic transmis-
sion. In healthy subjects, prefrontal dopamine activity
plays a key role in the sophisticated interplay between
bottom-up and top-down processes involved in smooth
pursuit eye movements. These findings crucially contrib-
ute to a better understanding of how oculomotor control is
modulated in healthy subjects.
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